HNRNPA1 and prostate carcinoma: In breast and prostate cancer cells, hnRNPA1 weakens programmed cell death by promoting the production of the anti-apoptotic splicing isomer Bcl-x and inhibiting the synthesis of the anti-apoptotic protein cIAP1 [32,33].